ASPHALION LISTED TOP PHARMACOVIGILANCE SOLUTIONS PROVIDER IN EUROPE 2021

ASPHALION LISTED TOP PHARMACOVIGILANCE SOLUTIONS PROVIDER IN EUROPE 2021

At ASPHALION, we are proud to announce that we have been listed as “TOP PHARMACOVIGILANCE SOLUTIONS PROVIDER in EUROPE 2021” by Pharma Tech Outlook. The publication has compiled a list of accomplished pharmacovigilance solution providers most suited for the current market requirements. Equipped with innovative technological capabilities, these pharmacovigilance service providers are set to transform the pharma landscape. We are happy to be among this year´s 10 companies that are at the forefront of providing Pharmacovigilance solutions and transforming businesses.

In 2021, we have launched a new EU Local Contact Network to provide local pharmacovigilance support to any EU country in order to implement our global solutions for the externalisation of pharmacovigilance services, the European Qualified Person for Pharmacovigilance (EU-QPPv) and the Pharmacovigilance System outsourcing. This allows our clients to have a single point management of LPPVs across Europe. Also, ASPHALION has its own PV system with a validated PV database that has successfully been audited in the last 15 years, with 0 critical findings and is ISO certificated with yearly renewal without even a minor finding.

Also, we continue delivering the following additional PV services:

  • Audit PV System and support for set up of Quality System
  • Preparation of PSMF, RMP, PSURs
  • Handling of Case Management and Signal Management
  • Global and local literature searches
  • Data entry in PV databases and hosting
  • UK Qualified Person for Pharmacovigilance (UK-QPPv) and National Person for Pharmacovigilance
  • Digital Media Screening
  • Medical information
  • Vigilance for Medical Devices and cosmetics

At ASPHALION, we are very grateful to have received this recognition and would like to thank everyone involved. The award is a recognition of ASPHALION´s excellence in PV: we have a strong track record, knowledge and capacity to deliver the best solutions for our PV clients.

Pharma Tech Outlook is a monthly publication bringing forth real world solutions, news and insights into the pharmaceutical and drug development space. With industry leading contributors, Pharma Tech Outlook brings together a unique network of peers who share experiences, ideas, and techniques with each other and the larger scientific community.

Have a look at the interview with our CEO, Nuria Romero, HERE.

For further information, you can contact us at: info@asphalion.com

ASPHALION | BIOCIDES
ASPHALION | EMPLOYEES DEVELOPMENT